Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of S-005151 in patients with knee osteoarthritis undergoing high tibial osteotomy and arthroscopic microfracture
jRCT2021200034Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Feb 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing S-005151 with Placebo (2 arms). Primary endpoint: Safety. Started Feb 2021; status: completed.
02
Drugs
redasemtide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2021200034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021200034.